Clinical Trial | Prof. Nikolaos Korfiatishttps://nkorf.github.io/tags/clinical-trial/Clinical TrialHugoBlox Kit (https://hugoblox.com)en-usThu, 01 Jan 2026 00:00:00 +0000https://nkorf.github.io/media/icon_hu_cd51c91342a84ed6.pngClinical Trialhttps://nkorf.github.io/tags/clinical-trial/Association patterns among patient-reported adverse events in advanced NSCLC: A post-hoc analysis of the CLIMEDIN randomized controlled trialhttps://nkorf.github.io/publications/kosmidis2026jco/Thu, 01 Jan 2026 00:00:00 +0000https://nkorf.github.io/publications/kosmidis2026jco/Clinico-pathological and genomic features of HER2-low early Breast Cancer (eBC). Results of retrospective analysis of seven adjuvant trials by the Hellenic Cooperative Oncology Group (HeCOG)https://nkorf.github.io/publications/lakis2026ccr/Thu, 01 Jan 2026 00:00:00 +0000https://nkorf.github.io/publications/lakis2026ccr/Comprehensive Molecular Profiling of Advanced NSCLC in Greek Patients: A Prospective HeCOG Studyhttps://nkorf.github.io/publications/kosmidis2026ctrc/Thu, 01 Jan 2026 00:00:00 +0000https://nkorf.github.io/publications/kosmidis2026ctrc/Detection of germline and somatic pathogenic variants in patients with de novo metastatic breast cancer (dnMBC) and assessment of their prognostic relevance: A Hellenic Cooperative Oncology Group (HeCOG) translational cohort studyhttps://nkorf.github.io/publications/efountzilas2026ccr/Thu, 01 Jan 2026 00:00:00 +0000https://nkorf.github.io/publications/efountzilas2026ccr/Phase Ib-II Study of Ramucirumab Combined with Nab-paclitaxel and Gemcitabine as First-line Treatment in Patients With Advanced Pancreatic Adenocarcinoma (RACING)https://nkorf.github.io/publications/papaxoinis2026ctrc/Thu, 01 Jan 2026 00:00:00 +0000https://nkorf.github.io/publications/papaxoinis2026ctrc/SNF-CLIMEDIN: A Randomized Trial of Digital Support and Intervention in Patients With Advanced Non–Small Cell Lung Cancer. A Hellenic Cooperative Oncology Group Studyhttps://nkorf.github.io/publications/kosmidis2026jcocci/Thu, 01 Jan 2026 00:00:00 +0000https://nkorf.github.io/publications/kosmidis2026jcocci/Anti-EGFR re-challenge with chemotherapy in RAS wild-type advanced colorectal cancer (A-REPEAT study): efficacy and correlations with tissue and plasma genotypinghttps://nkorf.github.io/publications/sgouros2025esmogi/Wed, 01 Jan 2025 00:00:00 +0000https://nkorf.github.io/publications/sgouros2025esmogi/Clinical outcomes and important prognostic biomarkers following dose-dense sequential adjuvant chemotherapy (dds-CT) in early breast cancer (eBC): Pooled-analysis of individual patient datahttps://nkorf.github.io/publications/goussia2025esmoopen/Wed, 01 Jan 2025 00:00:00 +0000https://nkorf.github.io/publications/goussia2025esmoopen/Clinico-pathological and genomic features of HER2-low early Breast Cancer (eBC). Results of retrospective analysis of seven adjuvant trials by the Hellenic Cooperative Oncology Group (HeCOG)https://nkorf.github.io/publications/lakis2025sabcs/Wed, 01 Jan 2025 00:00:00 +0000https://nkorf.github.io/publications/lakis2025sabcs/Detection of germline and somatic pathogenic variants in patients with de novo metastatic breast cancer (dnMBC) and assessment of their prognostic relevance: A Hellenic Cooperative Oncology Group (HeCOG) translational cohort studyhttps://nkorf.github.io/publications/efountzilas2025sabcs/Wed, 01 Jan 2025 00:00:00 +0000https://nkorf.github.io/publications/efountzilas2025sabcs/Frequency of Adverse Events Reported Digitally by Patients with Advanced NSCLC: Analysis From CLIMEDIN, a HeCOG Studyhttps://nkorf.github.io/publications/kosmidis2025jto/Wed, 01 Jan 2025 00:00:00 +0000https://nkorf.github.io/publications/kosmidis2025jto/Intercalated Avelumab plus platinum-based chemotherapy in patients with Extensive-Stage Small-Cell Lung cancer (PAVE): Final outcome, immunophenotypic and biomarker analysis of a multi-center phase II Hellenic Cooperative Oncology Group studyhttps://nkorf.github.io/publications/linardou2025ejc/Wed, 01 Jan 2025 00:00:00 +0000https://nkorf.github.io/publications/linardou2025ejc/SNF-CLIMEDIN: A HECOG prospective randomized trial of digital support and intervention in patients with advanced NSCLC—Final resultshttps://nkorf.github.io/publications/kosmidis2025jco/Wed, 01 Jan 2025 00:00:00 +0000https://nkorf.github.io/publications/kosmidis2025jco/The role of Cabazitaxel in Patients With Castration-Resistant and Osseous Metastases Prostate Cancer: A Hellenic Cooperative Oncology Group Phase II Studyhttps://nkorf.github.io/publications/liontos2025cgu/Wed, 01 Jan 2025 00:00:00 +0000https://nkorf.github.io/publications/liontos2025cgu/Analysis of evolution of patient reported side effects during treatment for advanced NSCLChttps://nkorf.github.io/publications/linardou2024aoo/Mon, 01 Jan 2024 00:00:00 +0000https://nkorf.github.io/publications/linardou2024aoo/Final outcome, immunophenotypic and biomarker analysis of intercalated avelumab plus platinum-based chemotherapy in patients with extensive-stage small cell lung cancer (PAVE)https://nkorf.github.io/publications/mountzios2024esmoopen/Mon, 01 Jan 2024 00:00:00 +0000https://nkorf.github.io/publications/mountzios2024esmoopen/SNF-CLIMEDIN: A prospective randomized trial of digital intervention in patients with advanced NSCLC—A HeCOG studyhttps://nkorf.github.io/publications/kosmidis2024jco/Mon, 01 Jan 2024 00:00:00 +0000https://nkorf.github.io/publications/kosmidis2024jco/Clinical and molecular study with digital support of advanced non-small cell lung cancer patients: SNF-CLIMEDIN, a prospective randomized Hellenic Cooperative Oncology Group studyhttps://nkorf.github.io/publications/linardou2023aoo/Sun, 01 Jan 2023 00:00:00 +0000https://nkorf.github.io/publications/linardou2023aoo/